Hostname: page-component-7c8c6479df-94d59 Total loading time: 0 Render date: 2024-03-27T18:04:27.227Z Has data issue: false hasContentIssue false

Patient characteristics and predictors of completion in residential treatment for substance use disorders

Published online by Cambridge University Press:  02 January 2018

Giles Newton-Howes
Affiliation:
Otago University, Wellington, New Zealand
James Stanley
Affiliation:
Otago University, Wellington, New Zealand
Rights & Permissions [Opens in a new window]

Abstract

Aims and method

To identify the patient characteristics and rates of retention in a residential rehabilitation drug and alcohol service (Springhill) based on an eclectic model of care. Patients were assessed using the Alcohol and Drug Outcome Measure (ADOM), a brief tool designed for the New Zealand setting. We looked at correlations between demographic, social and drug use parameters. Logistic regression assessed the relative impact of each variable on completion.

Results

The 183 patients who completed the data collection did not differ from 47 non-completers by demographic data; 62.2% of patients completed the programme, with equal number of men and women. One in five participants was Maori, the indigenous minority. Alcohol (51.9%) was the commonest drug of misuse, with methamphetamine (16.4%) and cannabis (14.2%) also significant. Completers were more likely to be Maori, have conflict with family and housing problems, although the last became non-significant in logistic regression.

Clinical implications

Retention rates are higher in Springhill than in comparable programmes. Ethnicity and family conflict predict completion, although the reasons for this are unclear. ADOM is an effective tool that can be used in a clinical setting to enable analysis of service provision.

Type
Original Papers
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an open-access article published by the Royal College of Psychiatrists and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 2015

Substance use disorders (SUDs) are relapsing and remitting disorders that affect a significant proportion of the community. One-year prevalence rates of alcohol use disorders range from 3.5% Reference Wells, Browne, Scott, McGee, Baxter and Kokaua1 to 8.7%, Reference Hall, Teesson, Lynskey and Degenhardt2 with lifetime rates for SUDs reaching 12.3%. Reference Oakley Browne, Wells, Scott and Mcgee3 The commonest age of onset for alcohol and drug problems is early adulthood, Reference Kessler, Berglund, Demler, Jin, Merikangas and Walters4,Reference Wells, Bushnell, Hornblow, Joyce and Oakley-Browne5 although the diagnosis may not be stable at this point. Reference Wells, Horwood and Fergusson6 Not only are SUDs common, they cause significant social morbidity, Reference Wells, Browne, Scott, McGee, Baxter and Kokaua1 physical morbidity Reference Rehm, Mathers, Popova, Thavorncharoensap, Teerawattananon and Patra7 and mortality. Reference Lloyd, Barratt, Ferris, Best and Lubman8 The reasons for ongoing use in the face of such difficulties is unclear, however, this may be due to the compulsive nature of substance use. Reference Sellman9 Despite this, recovery from alcohol use is an achievable goal, Reference Sheedy and Whitter10 hastened by effective management strategies.

A wide range of treatment options are used clinically, adopting both harm reduction Reference Marlatt, Blume and Parks11 and abstinence Reference Ilgen, McKellar and Tiet12 models. The latter is often the preferred choice, yet the success of these treatments is well known to be poor. Reference Hunt, Barnett and Branch13 The most intensive intervention for addiction is residential rehabilitation, Reference Keen, Oliver, Rowse and Mathers14 used in most countries and considered integral by almost half addictions clinicians. Reference Gossop15 Drop-out remains a major difficulty for residential programmes Reference Gossop, Marsden, Stewart and Rolfe16,Reference Siqueland, Crits-Christoph, Frank, Daley, Weiss and Chittams17 and improved retention is related to improved outcomes. Reference Gossop, Marsden, Stewart, Lehmann, Edwards and Wilson18 Patient factors such as family involvement and employment improve retention, Reference Siddall and Conway19 as do interpersonal factors such as the therapeutic alliance. Reference Meier, Barrowclough and Donmall20 A number of programme factors may also be important, including the ratio of counsellors to patients and a structured programme of therapy, as well as a balance between contributing to the community, specific addictions work and free time. Reference Meier, Meier and Best21 Psychopathology has not been found to be correlated with outcome Reference Darke, Campbell and Popple22,Reference Mulder, Frampton, Peka, Hampton and Marsters23 and this is interpreted as support for residential treatment for patients with drug use disorders and coexisting mental disorder. Reference DeLeon, Melnick, Thomas, Kressel and Wexler24,Reference Brunette, Mueser and Drake25

Developing routine assessment of residential interventions enables both description of patients presenting to these services and analysis of outcome. Although previous research is a useful guide, it may not be generalisable. Country and culture are two factors that may have an impact on alcohol and drug use and its management. Reference Vitellone26,Reference Taylor, Thompson and Davis27 Similarly, the attitudes and beliefs of addictions clinicians are of significance in deciding who is referred for residential treatment. Reference Vederhus, Kristensen, Laudet and Clausen28 Differences in culture, Reference Huriwai, Sellman, Sullivan and Potiki29 policy, Reference Whiteford, Harris and Diminic30 funding and politics Reference Prussing31 shape service provision and necessitate country-specific research. They also point to the need for country-specific, ideally easy to implement, research tools that have the capacity to translate into routine clinical practice. Only one New Zealand study has examined residential interventions, Reference Mulder, Frampton, Peka, Hampton and Marsters23 despite the importance of understanding this costly intervention and for whom it is most appropriate. This study supported a ‘non-discriminating approach’ to referral but did not use New-Zealand-specific measures and assessed a long-term treatment setting. Replication and assessment in short-duration residential treatment settings is important to both compare outcomes and examine possible differences.

For these reasons, we investigated the outcomes in a short-duration (8-week), eclectic residential programme using a locally designed and validated tool and report on factors that were associated with programme completion.

Method

In total, 230 clients consecutively admitted to the Springhill residential rehabilitation programme were included in this study. These clients were admitted during 2011/2012. All completed standard clinical documentation on admission to Springhill and in addition were asked to complete an Alcohol and drug Outcome Measure (ADOM) on admission and discharge. The research was approved by the Southern Health and Disability Ethics Committee and the local district health board.

The programme

Springhill runs an 8-week residential rehabilitation programme for all substance use disorders. Up to 15 patients can be admitted at any one time. Patients undergo managed withdrawal with their referring teams before admission if this is considered necessary, particularly from high-dose alcohol. It is unique in New Zealand insofar as the clinical programme is delivered by clinicians from a district health board (a public health provider) but the facility is governed by a private trust. All clinicians are registered health practitioners with clinical expertise in addiction treatment. The programme has input from a substance misuse psychiatrist and general practitioner with a special interest in addictions providing medical oversight. The programme is abstinence based, including abstinence from tobacco, and draws on principles from the 12-step programme, cognitive-behavioural therapy, family systems theory and some elements of a therapeutic community. In this way it is similar to residential programmes elsewhere Reference Meier32 and would best be considered as eclectic. Each week is structured around facilitated large group sessions with all clients, supplemented by individual and family work. Exercise and involvement in the running of the facility are part of the programme. Each client has an individual therapist to work with alongside the group and all clients are reviewed medically and have access to psychiatric review if necessary. At the conclusion of the programme clients are referred back to their community addictions providers.

Client characteristics

Patients are accepted primarily from secondary addictions services in the community when this intervention has been ineffective as judged by their community clinician. There are few specific exclusion criteria and referrals are assessed on a case by case basis. Referrals are received from the lower North Island of New Zealand and include both rural and urban settings. Programme entry requires that there is a service to refer the client back to on completion. In the case of abrupt discharge each client has a person whom they have agreed to be contacted, with the referring service contacted the following day. If there are clinical concerns, a psychiatric crisis team is available to undertake assessment as deemed necessary. A clinical diagnosis of alcohol or drug dependence is a requisite for consideration for admission. Judicial direction is a specific exclusion criterion (i.e. clients cannot be legally directed into treatment at Springhill).

The ADOM tool

The ADOM is a brief tool to collect outcome data and measure improvements after intervention in substance dependence, specifically in a New Zealand setting. Part A of the tool is validated Reference DeLeon, Melnick, Thomas, Kressel and Wexler24 and part B is similar to other tools used to collect information on social support and context, in line with other addictions rating instruments. Reference Marsden, Farrell, Bradbury, Dale-Perera, Eastwood and Roxburgh33 Part A focuses on drug use, particularly number of days' use in the past 4 weeks and total use of alcohol in units, this being the most prevalent drug of misuse in New Zealand. Tobacco use is measured as average number of cigarettes a day. Part B asks clients to rate the frequency of problems in multiple social domains as a result of drug dependence, again in the past 4 weeks. These include problems related to physical health, mental health, conflict in interpersonal relationships, difficulties with work or other structured activity, housing and criminal activity. These are self-reported on a 1–5 Likert scale. A score of 1 represents no difficulty in the social variable measured, whereas a score of 5 represents daily or almost daily problems. These variables were measured for the 4 weeks preceding admission during engagement with community alcohol and drug services. This allowed for a measure of current social problems and can allow for examination of changes on these scales over time. The advantage of a self-report measure is its acceptability to patients and the reporting of perceived difficulty as assessed by the client.

Data collection and analysis

At admission basic demographic information was collected from the patient and the ADOM tool was completed by the patient with their admitting therapist. At discharge, all patients completed discharge paperwork with their discharge therapist and the ADOM tool was again administered at this point. If clients were discharged outside of working hours they were contacted the following day to complete the ADOM if this was possible. All analysis was carried out in SPSS 19 for Windows and undertaken by one of the authors (J.S.).

The primary goal of this analysis was to identify what, if any, factors were associated with retention in the programme to 8 weeks or attrition over the 8 weeks. The purpose of this analysis is to provide services with information about clients who are at greater likelihood of succeeding to completion. All demographic and ADOM data used in this analysis are based on the measures collected at admission.

Descriptive statistics on sociodemographic and basic clinical characteristics (as collected at admission) are reported as means, standard deviations and proportions as appropriate. Logistic regression analysis was used to examine unadjusted relationships between each of the potential predictor variables and the outcome of completing the programme (defined as 8 weeks' participation in the residential programme). The predictor list set was developed a priori.

To consider the potential impact of confounding on the modelled estimates, subsequent logistic regression analysis looked at adjusted estimates for programme completion. Adjusted results are presented in four blocks. First, sociodemographic variables (age, gender and ethnicity) were entered into the model. Block two consisted of adding the primary drug of dependence as identified by the patients themselves (simplified to alcohol, cannabis, amphetamine and other drugs (e.g. opioids) and no drug specified). The third block included adding physical and psychological health variables and finally, social variables including work, paid employment, housing and crime. The model was developed to identify for whom completion was most likely as a proxy marker for positive long-term outcomes.

Results

Patient demographic data

During the study period 230 patients were admitted to Springhill, of whom 183 (80%) completed ADOM data on admission and discharge. The 47 patients for whom complete data were not available did not differ from the included patient data-set on basic demographic data. Overall, 143 patients (62% of all admitted patients) completed the 8-week programme (including 2 patients who stayed 9 weeks and 1 patient who stayed 10 weeks). For those included in the analysis the average age was 37 years with equal numbers of men and women. The majority of clients (74%) were White, 21% were Maori and the remainder identified with other ethnic backgrounds. At the time of admission 33% of clients had a partner, although 1 in 5 declined to answer this question. These variables are similar to those of clients not included in further analysis and similar to the demographic of the region (Table 1).

TABLE 1 Demographic and drug use of the client group

Client status (at admission) Analysed data (n = 183) Missing data (n = 47) Total (n = 230) N valid by question
Age, years: mean (s.d.) 37.4 (11) 36.2 (11.5) 37.1 (11.1) 230 (100%)
Gender
    Male 96 (52.5%) 20 (58.8%) 116 (53.5%) 217 (94.3%)
    Female 87 (47.5%) 14 (41.2%) 101 (46.5%)
Ethnicity
    Maori 39 (21.3%) 3 (23.1%) 42 (21.4%) 196 (85.2%)
    White 136 (74.3%) 9 (69.2%) 145 (74%)
    Other specified 8 (4.4%) 1 (7.7%) 9 (4.6%)
Relationship status
    Partner 51 (32%) 8 (36%) 59 (33%) 181 (79%)
    No partner 108 (68%) 14 (64%) 122 (67%)
Main drug at admission
    Alcohol 95 (51.9%) 9 (33.3%) 104 (49.5%) 210 (91.3%)
    Cannabis 26 (14.2%) 7 (25.9%) 33 (15.7%)
    Amphetamine, other a 30 (16.4%) 5 (18.5%) 35 (16.7%)
    None selected 32 (17.5%) 6 (22.2%) 38 (18.1%)
Substance use in past 4 weeks by
main drug of dependence, b days:
mean (s.d.)
    Alcohol (n = 104) 13.2 (9.5) 11.1 (4.9) 13.1 (9.2) 95 (91.3%)
    Cannabis (n = 33) 16.4 (11.8) 12.7 (12.8) 15.6 (11.9) 26 (78.8%)
    Amphetamines c (n = 27) 4.2 (7.6) 9.3 (12.7) 4.9 (8.4) 23 (85.2%)
    Cigarettes (n = 230) 12.4 (12.8) 13.5 (11.7) 12.5 (12.6) 183 (79.6%)

a. A total of 8 clients reported using other substances outside the main categories.

b. Days' use represents the number of days' use of the substance identified as the primary drug of dependence by the client. The exception is mean number of days nicotine used; this is for the whole sample.

c. Amphetamine usage among those with amphetamine as main drug at admission.

Drug use variables

The commonest drug of dependence in the sample was alcohol with 51.9% of clients identifying this as their most problematic drug. Amphetamine, primarily methamphetamine (16.4%), and cannabis (14.2%) were the other significant primary drugs of misuse. Thirty-two patients could not identify a primary drug of misuse, having problems associated with multiple drug use. Eight patients identified sedatives, opioids or other drugs as their primary drug of dependence with no more than three in each group. Twelve patients used the intravenous route for drug administration in the 4 weeks before admission, with 3 patients sharing needles.

Patients with primary alcohol dependence drank on average 14 units a day in the month before admission, with alcohol consumed for 13 of the past 28 days. Those with cannabis dependence smoked on 16 of the past 28 days on average. The 27 patients with amphetamine dependence used on 4 of the 28 days before admission. All groups were engaged in community alcohol and drug out-patient programmes prior to their admission. Tobacco smoking was common in this group despite the admission criteria to Springhill identifying it as a smoke-free rehabilitation facility, with the expectation of discharge if smoking occurred during the admission.

Social variables

A quarter of clients stated their drug use led to daily physical health problems, with almost two-thirds identifying physical health problems occurring at least weekly and directly related to their drug use. Mental health problems occurred on a daily basis for one in seven patients, with three-quarters identifying mental health difficulties related to the use of drugs of dependence. Social difficulties were also common: 20% of patients recorded daily conflict with family or friends and almost two-thirds recognised conflict at least weekly. Recreational and work were similarly compromised, with 83% and 67% of clients respectively identifying problems at some point. Housing was a daily problem for three-quarters of clients. Despite the specific exclusion of referrals from the judicial systems, more than 90% of clients identified crime (other than the use of illicit substances) as related to their drug use, with more than half stating this was an almost daily problem.

Univariate predictors of programme completion

Sociodemographic, clinical and social variables were examined as univariate predictors of programme completion using logistic regression (Table 2). Identifying as Maori, conflict with family and problems with housing were associated with increased rate of retention. Only ethnicity had an odds ratio greater than 2. Drug of dependence was not associated with programme completion and no association was found between coexisting mental health problems and programme completion.

TABLE 2 Unadjusted odds ratios for completion of the 8-week residential rehabilitation programme among respondents with complete data (n = 183)

Factor Odds ratio (95% CI) P
Age (analysed in 5-year blocks) 1.13 (0.98, 1.29) 0.10
Gender
    Male 0.97 (0.53, 1.77) 0.92
    Female 1 (reference)
Ethnicity
    Maori 2.31 (1.02, 5.23) 0.04
    White/other 1 (reference)
Primary drug of dependence
    Alcohol 1 (reference) 0.74
    Cannabis 0.69 (0.29, 1.68)
    Amphetamine/other 0.66 (0.29, 1.54)
    None selected 0.85 (0.37, 1.95)
Physical health problems a 1.05 (0.87, 1.27) 0.64
Mental health difficulties a 1.02 (0.83, 1.24) 0.97
Conflict with family a 1.30 (1.04, 1.62) 0.01
Social role difficulties a 1.17 (0.96, 1.42) 0.08
Employment problems a 1.10 (0.92, 1.32) 0.24
Housing problems a 1.47 (1.10, 1.96) 0.03
Crime a 1.11 (0.87, 1.41) 0.40

a. Odds ratios are increase in odds of completion per one unit in change in the scale.

Regression modelling of programme completion

Logistic regression was carried out using a four-block, sequential adjustment method. Regression estimates (presented as odds ratios and 95% confidence intervals) are presented in Table 3. Model A included age, gender and ethnicity as predictors of treatment, model B added in the primary drug of dependence, while model C added scores measuring physical health, mental health and levels of conflict with family. The fully adjusted model (model D) added variables on social role, employment, housing and crime.

TABLE 3 Logistic regression of factors associated with completion of residential treatment programme among clients with complete data (n = 183)

Model A Model B Model C Model D
Response Odds ratio
(95% CI)
P Odds ratio
(95% CI)
P Odds ratio
(95% CI)
P Odds ratio
(95% CI)
P
Age (per 5 years) 1.14 (0.99, 1.32) 0.07 1.12 (0.96, 1.31) 0.14 1.1 (0.94, 1.29) 0.231 1.08 (0.91, 1.27) 0.38
Gender
    Male 1.01 (0.55, 1.87) 0.97 1.03 (0.56, 1.92) 0.92 0.81 (0.41, 1.61) 0.55 0.80 (0.39, 1.63) 0.54
    Female 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Ethnicity
    Maori 2.48 (1.08, 5.66) 0.03 2.57 (1.10, 5.98) 0.030 2.83 (1.18, 6.75) 0.02 2.82 (1.15, 6.92) 0.02
    White/other 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Primary drug of
dependence
    Alcohol 1 (reference) 0.93 1 (reference) 0.92 1 (reference) 0.95
    Cannabis 0.72 (0.27, 1.89) 0.70 (0.26, 1.93) 0.74 (0.26, 2.08)
    Amphetamine/other 0.88 (0.35, 2.17) 0.91 (0.36, 2.28) 0.94 (0.36, 2.47)
    None selected 0.93 (0.40, 2.19) 0.88 (0.36, 2.13) 0.88 (0.36, 2.15)
Physical health problems a 1.09 (0.86, 1.39) 0.46 1.11 (0.86, 1.42) 0.434
Mental health difficulties a 0.86 (0.66, 1.12) 0.26 0.85 (0.64, 1.12) 0.248
Conflict with family a 1.47 (1.12, 1.93) 0.01 1.44 (1.03, 2.00) 0.031
Social role difficulties a 1.01 (0.74, 1.38) 0.96
Employment problems a 1.13 (0.92, 1.39) 0.25
Housing problems a 1.35 (0.97, 1.89) 0.078
Crime a 1.00 (0.73, 1.36) 1

a. Odds ratios are increase in odds of completion per one unit in change in the scale.

In the fully adjusted regression model (model D), only increasing conflict with family and ethnicity (being Maori) significantly predicted completion of the residential rehabilitation programme. Of all variables, being Maori more than doubled the odds of programme completion. Drug use was not predictive of completion. Notably, there was significant use in the 28 days prior to admission and no medical detoxification offered. This suggests clients did not leave rehabilitation because of withdrawal phenomena. Housing problems were not significantly associated with programme completion in the full model, but the magnitude of the observed odds ratio and confidence interval (OR = 1.35, 95% CI 0.97, 1.89) suggest that such problems might also be associated with increased rates of programme completion. The modelling was reviewed using ordinal regression with weeks completed from 1 to 8 as the step-wise variable. This statistical model was largely the same as the linear regression, with the only alteration being the somewhat increased association between criminal activity and completion. Using ordinal modelling criminal activity significantly predicted greater length of stay (regression model available on request).

Discussion

The current research uses a specific tool, ADOM, to assess patient characteristics and potential indicators of programme completion within a residential rehabilitation setting in New Zealand. The ADOM tool was acceptable to patients with high completion rates, despite more than a third of patients leaving the service early. It was easily intercalated into routine clinical care and specific researchers were not used to collect this information, indicating its capacity for translation for routine use (see www.matuaraki.org.nz/supporting-workforce/adom). The potential for use throughout New Zealand would allow for in-depth understanding of addiction service use and potentially prediction of service matching.

Patients entering rehabilitation report high ongoing use of alcohol and other drugs, despite being engaged in community treatment programmes prior to entry. This implies difficulties for some patients with SUDs despite community intervention and the need to develop and deliver alternative interventions. Alcohol remains the most significant drug of dependence in those referred for residential support, although methamphetamine use is common. Low opioid use and low injecting rates may reflect the effectiveness of opioid substitution regimes. Reference Sheerin, Green, Sellman, Adamson and Deering34 The need for a drug-free environment is well recognised as a component in recovery for some patients and this is likely to remain the case. Completion rates of greater than 60% are high, with other programmes reporting rates as low as 16%, Reference Johns, Baker, Webster and Lewin35 and likely reflect a physical, social and therapeutic environment that is acceptable to patients. The lack of association between specific alcohol or drug use and completion demonstrates the ability to remain in a residential setting despite the varying biological impact of different drug classes and argues for a generic approach to treatment rather than one that is drug specific.

Significant morbidity is reported in physical, psychological and social domains by the patients in this study. These problems are directly related to drug use and small changes in use are likely to be associated with significant benefits to health, relationships and well-being. Previous economic analysis indicates major benefits associated with effective addictions intervention also. Reference Bouchery, Harwood, Sacks, Simon and Brewer36 The relative failure of community intervention for this cohort argues in favour of residential intervention, particularly if retention is high, and implies improved prognosis. This is the case for Springhill and may relate to positive longer-term outcomes. Reference Zhang, Friedmann and Gerstein37,Reference Simpson, Joe and Brown38 Follow-up studies will enable further examination of longer-term benefits and overcome the limitation of using completion as a proxy marker for improved prognosis.

Identifying who is likely to benefit most from residential treatment allows for a more targeted approach to management. Prior research has recommended a ‘non-discriminatory approach to referral’ and no clear indicators are apparent in the current literature base. Using regression analyses to consider the impact of several factors likely to alter treatment completion, we are able to show that Maori, the indigenous minority in New Zealand, and those with conflict in the home are more likely to complete the programme. The programme includes the capacity for patients to engage with a cultural assessment but does not include individual or group activities that are specifically culturally oriented. Previous research identifies greater social morbidity in Maori in an out-patient addictions setting Reference Huriwai, Sellman, Sullivan and Potiki39 and greater satisfaction with a culturally specific service. Cultural factors have been a point of focus in policy debate about the provision of services, Reference Huriwai, Sellman, Sullivan and Potiki29 with some advocating for a culturally appropriate approach research methodology frame, although support (and the application) of this is very limited. The current findings suggest Maori manage well in a generic eclectic setting. This does not indicate a generic service is likely to outperform a culturally specific service; rather, Maori are more likely than clients of other ethnicities to complete this programme. Ethnicity is not a proxy marker for social disadvantage as measured by social role difficulties, employment, housing problems and crime in this study as the linear regression of model D elucidates. Understanding the impact of homelessness in dependence is complex, Reference McNaughton40 although the parsimonious explanation of having basic needs met does not preclude the potential for recovery and may be an important component of successful recovery.

The findings of this research are circumscribed by the limitations related to a naturalistic cohort design. Not all questions were completed by all patients and this leads to a weakening in the analysis, however, the advantage of developing the data collection as part of routine care confirms its utility and capacity for translation from research to routine use. The benefits of using a country-specific tool may counterbalance the restrictions of its limited use. The outcome measure of programme completion is useful, Reference Zhang, Friedmann and Gerstein37,Reference Simpson, Joe, Broome, Hiller, Knight and Rowan-Szal41 however, long-term abstinence is a more powerful outcome. Follow-up studies are necessary to assess this.

This study highlights the acceptability for some of a residential setting to address their substance dependence. Significant pre-entry drug use, despite community care, does not prevent engagement and abstinence-based programme completion. Maori and homeless patients engage well and these factors predict retention. ADOM is a potentially valuable tool for monitoring outcome from a residential setting and has wider potential use in New Zealand.

Footnotes

Declaration of interest

None.

References

1 Wells, JE, Browne, MAO, Scott, KM, McGee, MA, Baxter, J, Kokaua, J. Prevalence, interference with life and severity of 12 month DSM-IV disorders in Te Rau Hinengaro: The New Zealand Mental Health Survey. Aust NZ J Psychiatry 2006; 40: 845–54.Google Scholar
2 Hall, W, Teesson, M, Lynskey, M, Degenhardt, L. The 12-month prevalence of substance use and ICD-10 substance use disorders in Australian adults: findings from the National Survey of Mental Health and Well-Being. Addiction. 1999; 94: 1541–50.CrossRefGoogle ScholarPubMed
3 Oakley Browne, MA, Wells, JE, Scott, KM, Mcgee, MA. Lifetime prevalence and projected lifetime risk of DSM-IV disorders in Te Rau Hinengaro: the New Zealand Mental Health Survey. Aust NZ J Psychiatry 2006; 40: 865–74.Google Scholar
4 Kessler, RC, Berglund, P, Demler, O, Jin, R, Merikangas, KR, Walters, EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593.CrossRefGoogle ScholarPubMed
5 Wells, JE, Bushnell, JA, Hornblow, AR, Joyce, PR, Oakley-Browne, MA. Christchurch Psychiatric Epidemiology Study, Part I: Methodology and lifetime prevalence for specific psychiatric disorders. Aust NZ J Psychiatry 1989; 23: 315–26.Google Scholar
6 Wells, JE, Horwood, LJ, Fergusson, DM. Stability and instability in alcohol diagnosis from ages 18 to 21 and ages 21 to 25 years. Drug Alcohol Dep 2006; 81: 157–65.CrossRefGoogle ScholarPubMed
7 Rehm, J, Mathers, C, Popova, S, Thavorncharoensap, M, Teerawattananon, Y, Patra, J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009; 373: 2223–33.Google Scholar
8 Lloyd, B, Barratt, MJ, Ferris, J, Best, D, Lubman, DI. Factors influencing mortality among alcohol and drug treatment clients in Victoria, Australia: the role of demographic and substance use characteristics. Aust NZ J Psychiatry 2013; 47: 859–67.CrossRefGoogle ScholarPubMed
9 Sellman, D. The 10 most important things known about addiction. Addiction 2010; 105: 613.Google Scholar
10 Sheedy, CK, Whitter, M. Guiding Principles and Elements Of Recovery-Oriented Systems of Care: What do We Know from the Research? HHS Publication No. (SMA) 09-4439. Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, 2009.Google Scholar
11 Marlatt, GA, Blume, AW, Parks, GA. Integrating harm reduction therapy and traditional substance abuse treatment. J Psychoactive Drugs 2001; 33: 1321.CrossRefGoogle ScholarPubMed
12 Ilgen, M, McKellar, J, Tiet, Q. Abstinence self-efficacy and abstinence 1 year after substance use disorder treatment. J Consult Clin Psychol 2005; 73: 1175.Google Scholar
13 Hunt, WA, Barnett, LW, Branch, LG. Relapse rates in addiction programs. J Clin Psychol 1971; 27: 455–6.Google Scholar
14 Keen, J, Oliver, P, Rowse, G, Mathers, N. Residential rehabilitation for drug users: a review of 13 months' intake to a therapeutic community. Fam Pract 2001; 18: 545–8.CrossRefGoogle ScholarPubMed
15 Gossop, M. The treatment mapping survey; a descriptive study of drug and alcohol treatment responses in 23 countries. Drug Alcohol Depend 1995; 39: 714.CrossRefGoogle ScholarPubMed
16 Gossop, M, Marsden, J, Stewart, D, Rolfe, A. Treatment retention and 1 year outcomes for residential programmes in England. Drug Alcohol Depend 1999; 57: 8998.Google Scholar
17 Siqueland, L, Crits-Christoph, P, Frank, A, Daley, D, Weiss, R, Chittams, J, et al. Predictors of dropout from psychosocial treatment of cocaine dependence. Drug Alcohol Depend 1998; 52: 113.Google Scholar
18 Gossop, M, Marsden, J, Stewart, D, Lehmann, P, Edwards, C, Wilson, A, et al. Substance use, health and social problems of service users at 54 drug treatment agencies. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry 1998; 173: 166–71.CrossRefGoogle ScholarPubMed
19 Siddall, JW, Conway, GL. Interactional variables associated with retention and success in residential drug treatment. Subst Use Misuse 1988; 23: 1241–54.Google Scholar
20 Meier, PS, Barrowclough, C, Donmall, MC. The role of the therapeutic alliance in the treatment of substance misuse: a critical review of the literature. Addiction 2005; 100: 304–16.Google Scholar
21 Meier, PS, Meier, PS, Best, D. Programme factors that influence completion of residential treatment. Drug Alcohol Rev 2006; 25: 349–55.Google Scholar
22 Darke, S, Campbell, G, Popple, G. Retention, early dropout and treatment completion among therapeutic community admissions. Drug Alcohol Rev 2012; 31: 6471.Google Scholar
23 Mulder, R, Frampton, C, Peka, H, Hampton, G, Marsters, T. Predictors of 3-month retention in a drug treatment therapeutic community. Drug Alcohol Rev 2009; 28: 366–71.CrossRefGoogle Scholar
24 DeLeon, G, Melnick, G, Thomas, G, Kressel, D, Wexler, HK. Motivation for treatment in a prison based therapeutic community. Am J Drug Alcohol Abuse 2000; 26: 3346.Google Scholar
25 Brunette, M, Mueser, K, Drake, R. A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders. Drug Alcohol Rev 2004; 23: 471–81.Google Scholar
26 Vitellone, N. Habitus and social suffering: culture, addiction and the syringe. Sociol Rev 2004; 52 (s2): 129–47.Google Scholar
27 Taylor, K, Thompson, S, Davis, R. Delivering culturally appropriate residential rehabilitation for urban Indigenous Australians: a review of the challenges and opportunities. Aust NZ J Publ Health 2010; 34(s1): S3640.Google Scholar
28 Vederhus, JK, Kristensen, Ø, Laudet, A, Clausen, T. Attitudes towards 12-step groups and referral practices in a 12-step naive treatment culture; a survey of addiction professionals in Norway. BMC Health Serv Res 2009; 9: 147.CrossRefGoogle Scholar
29 Huriwai, T, Sellman, JD, Sullivan, P, Potiki, TL. Optimal treatment for Maori with alcohol and drug-use-related problems: an investigation of cultural factors in treatment. Subst Use Misuse 2000; 35: 281300.CrossRefGoogle ScholarPubMed
30 Whiteford, H, Harris, M, Diminic, S. Mental health service system improvement: translating evidence into policy. Aust NZ J Psychiatry 2013; 47: 703–6.Google Scholar
31 Prussing, E. Sobriety and its cultural politics: an ethnographer's perspective on ‘culturally appropriate’ addiction services in Native North America. Ethos 2008; 36: 354–75.Google Scholar
32 Meier, P. A National Survey of Retention in Residential Rehabilitation Services. National Treatment Agency for Substance Misuse, 2005.Google Scholar
33 Marsden, J, Farrell, M, Bradbury, C, Dale-Perera, A, Eastwood, B, Roxburgh, M, et al. Development of the treatment outcomes profile. Addiction 2008; 103: 1450–60.Google Scholar
34 Sheerin, I, Green, T, Sellman, D, Adamson, S, Deering, D. Reduction in crime by drug users on a methadone maintenance therapy programme in New Zealand. NZ Med J 2004; 117: 110.Google Scholar
35 Johns, K, Baker, A, Webster, RA, Lewin, TJ. Factors associated with retention in a long-term residential rehabilitation programme for women with substance use problems. Ment Health Subst Use Dual Diagn 2009; 2: 4051.Google Scholar
36 Bouchery, EE, Harwood, HJ, Sacks, JJ, Simon, CJ, Brewer, RD. Economic costs of excessive alcohol consumption in the US, 2006. Am J Prevent Med 2011; 41: 516–24.Google Scholar
37 Zhang, Z, Friedmann, PD, Gerstein, DR. Does retention matter? Treatment duration and improvement in drug use. Addiction 2003; 98: 673–84.Google Scholar
38 Simpson, DD, Joe, GW, Brown, BS. Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav 1997; 11: 294.CrossRefGoogle Scholar
39 Huriwai, T, Sellman, J, Sullivan, P, Potiki, T. A clinical sample of Maori being treated for alcohol and drug problems in New Zealand. NZ Med J 1998; 111: 145.Google Scholar
40 McNaughton, CC. Transitions through homelessness, substance use, and the effect of material marginalization and psychological trauma. Drugs Educ Prev Policy 2008; 15: 177–88.Google Scholar
41 Simpson, DD, Joe, GW, Broome, KM, Hiller, ML, Knight, K, Rowan-Szal, GA. Program diversity and treatment retention rates in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav 1997; 11: 279.Google Scholar
Figure 0

TABLE 1 Demographic and drug use of the client group

Figure 1

TABLE 2 Unadjusted odds ratios for completion of the 8-week residential rehabilitation programme among respondents with complete data (n = 183)

Figure 2

TABLE 3 Logistic regression of factors associated with completion of residential treatment programme among clients with complete data (n = 183)

Submit a response

eLetters

No eLetters have been published for this article.